These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [The effect of phencylidine derivatives ketamine (CI 581) on the cardiovascular system of the man]. Kreuscher H; Gauch H Anaesthesist; 1967 Aug; 16(8):229-33. PubMed ID: 5588810 [No Abstract] [Full Text] [Related]
24. Cardiovascular action of a novel vasodepressor, a hydroxamic acid. Kehl H J Am Osteopath Assoc; 1973 Jan; 72(5):498-501. PubMed ID: 4486481 [No Abstract] [Full Text] [Related]
25. [The effect of tetrodotoxin (TTX) on cardiovascular dynamics]. Kuno M; Goto K; Oka S; Negishi H; Hosoyamada A; Inada Y Masui; 1988 May; 37(5):530-5. PubMed ID: 3411775 [No Abstract] [Full Text] [Related]
26. Cardiovascular effects of glucagon in the intact anesthetized and hepatectomized dog. Pappas G; Guillen J; Aldrete JA Surgery; 1970 Aug; 68(2):363-8. PubMed ID: 5450717 [No Abstract] [Full Text] [Related]
27. Cardiovascular effects of anesthetic induction with ketamine. Waxman K; Shoemaker WC; Lippmann M Anesth Analg; 1980 May; 59(5):355-8. PubMed ID: 7189381 [TBL] [Abstract][Full Text] [Related]
28. Cardiovascular effects of synthetic physalaemin. Nakano J; Darrow BA; McCurdy JR Arch Int Pharmacodyn Ther; 1968 Apr; 172(2):429-34. PubMed ID: 5684254 [No Abstract] [Full Text] [Related]
29. Hemodynamic effects of experimental hypercitremia. Corbascio AN; Smith NT Anesthesiology; 1967; 28(3):510-6. PubMed ID: 6023523 [No Abstract] [Full Text] [Related]
30. Effects of CL 1848C, a new dissociative anesthetic, on the canine cardiovascular and respiratory systems. Traber DL; Priano LL; Wilson RD J Pharmacol Exp Ther; 1970 Nov; 175(2):395-403. PubMed ID: 5481707 [No Abstract] [Full Text] [Related]
32. [Study of cardiovascular effect of neuroleptanesthesia (Part I)--cardiovascular effect of pentazocine (author's transl)]. Sone T Masui; 1980 Mar; 29(3):225-31. PubMed ID: 7373840 [No Abstract] [Full Text] [Related]
33. [Changes induced by various concentrations of halothane in the cardiovascular system. (Experimental study)]. Tonelli F; Fantera A Acta Anaesthesiol; 1970; 31():Suppl:1-15. PubMed ID: 5538009 [No Abstract] [Full Text] [Related]
34. Effects of acetyl strophanthidin on cardiovascular function in intact, conscious dogs. Kumar R; Hood WB; Gilmour DP; Abelmann WH J Pharmacol Exp Ther; 1972 Jan; 180(1):24-30. PubMed ID: 5010415 [No Abstract] [Full Text] [Related]
35. The effects of bradykinin on the pulmonary veins. Hyman AL J Pharmacol Exp Ther; 1968 May; 161(1):78-87. PubMed ID: 5648503 [No Abstract] [Full Text] [Related]
36. The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects. Osborne MW; Wenger JJ; Willems W J Pharmacol Exp Ther; 1971 Sep; 178(3):517-28. PubMed ID: 5571901 [No Abstract] [Full Text] [Related]
38. Alteration of cardiac contractility and hemodynamics by phosphodiesterase inhibition. Hohl MK; Jolley WB; Smith LL Surg Forum; 1974; 25(0):158-60. PubMed ID: 4373844 [No Abstract] [Full Text] [Related]
39. Influence of selected antiarrhythmic drugs on the hemodynamic parameters in rabbits during anesthesia. Part III. Ketamine anesthesia. Orszulak-Michalak D Pol J Pharmacol; 1995; 47(5):407-16. PubMed ID: 8868132 [TBL] [Abstract][Full Text] [Related]
40. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat. Nekooeian AA; Tabrizchi R Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]